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  PERMANGANOMETRIC DETERMINATION OF 
ETAMSYLATE IN BULK DRUG 
AND IN TABLETS 
One titrimetric and two spectrophotometric methods which are simple, selec-
tive, sensitive, accurate, precise and economical for the determination of etam-
sylate (ETM) in bulk drug and in tablets employing permanganate as the oxidi-
metric reagent are described. In titrimetry, ETM is titrated directly with perman-
ganate in sulphuric acid medium. A direct spectrophotometry (method A) invol-
ves treating the aqueous solution of the drug with permanganate in alkaline 
medium and measuring the bluish green product at 610 nm. In indirect spectro-
photometry (method B), the drug solution was treated with a fixed concen-
tration of permanganate in H2SO4 medium, and after a specified time, the un-
reacted permanganate was measured at 545 nm. The molar combining ratio in 
titrimetry and the optimum assay conditions were studied. Titrimetry is applica-
ble over 1–10 mg range and the calculations are based on a 1:4 (ETM:KMnO4) 
molar ratio. In spectrophotometry, Beer’s law is obeyed over 0.5- 5.0 and 1.5–
–15 µg ml
-1 for method A and B, respectively. The molar absorptivity values are 
calculated to be 2.79×10
4 and 4.17×10
4 l mol
-1 cm
-1 for method A and B, res-
pectively and the corresponding sandell sensitivity values are 0.0094 and 
0.0063 µg cm
-2. The limits of detection (LOD) and quantification (LOQ) are also 
reported for spectrophotometric methods. The applicability of the developed 
methods was demonstrated by the determination of etamsylate in pure drug as 
well as in commercial dosage forms. 
Key words: etamsylate; assay; titrimetry; spectrophotometry; permanga-
nate; pharmaceuticals. 
 
 
Etamsylate (ETM), chemically known as 2,5-di-
hydroxybenzene sulphonic acid with ethylene diamine 
[1] (Fig. 1), has haemostatic properties. It is used as a 
systematic haemostatic agent capable of reducing ca-
pillary bleeding in the presence of normal number of 
platelets. ETM is used in the treatment of capillary he-
morrhage, hematemesis, hemopthsis, malena, hema-
turia, epistaxis, menorrhagia and post partum hemor-
rhage [2]. Owing to its great therapeutical importance 
and widespread use, several procedures have been 
reported for the determination of ETM in biological 
fluids and pharmaceutical formulations. The determi-
nation of ETM in rabbit serum [3], human urine [4] and 
biological fluids [5] has been reported employing UV- 
-spectrophotometry, capillary electrophoresis and ki-
netic spectrophotometry, respectively. ETM in phar-
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maceuticals has been determined by a variety of ana-
lytical techniques including HPLC [6,7], HPTLC [8,9], 
UV-spectrophotometry [10,11], irreversible biampero-
metry [12], adsorptive stripping voltammetry [13], flow 
injection potentiometry [14] and chemiluminescence 
spectrophotometry [15,17]. The above-mentioned tech-
niques, of course, are sensitive enough but are ex-
pensive. The reported UV spectrophotometric proce-
dures [10,11] have been applied for the assay of ETM 
when present in combination with mefenamic acid. 
 
Figure 1. Structure of etamsylate. 
As titrimetric and visible spectrophotometric as-
says offer significant economic advantages over the 
techniques cited above, the aim of the present investi-
gation was to develop simple and sensitive yet econo-K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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mical methods for the determination of ETM in dos-
age forms. 
The literature survey revealed that no titrimetric 
assay has ever been reported for ETM. The reported 
visible spectrophotometric methods, although a coup-
le of them sensitive, suffer from one or other disad-
vantage such as use of costly reagent and poor sen-
sitivity [23], heating step [21,22] or narrow linear ran-
ge [5] (Table 1). Hence, there is a need to develop 
simple, selective and sensitive procedures for the de-
termination of ETM in pharmaceuticals. 
In this paper, we describe the development and 
validation of one titrimetric and two spectrophotomet-
ric methods for the determination of ETM in bulk drug 
and in tablets using permanganate as a reagent. Per-
manganate has earlier been used for the assay of 
thioxanthines [24], isoniazid [25], methyl thiouracil 
[26], chloramphenicol [27], amidopyrine [28], valdeco-
xib [29], nicotine [30], tramodol HCl [31], cefuroxime 
[32], diloxamide [33] and pentacozine [34], to mention 
a few and its use for the determination of ETM has 
not been reported. The methods developed offer the 
advantages of simplicity, speed, accuracy and preci-
sion without the need for costly equipment/chemicals. 
EXPERIMENTAL 
Apparatus 
All absorbance measurements were made on a 
Systronics model 106 digital spectrophotometer (Ah-
medabad, India) provided with 1-cm matched quartz 
cells. 
Materials and reagents 
All chemicals and reagents used were of analy-
tical or pharmaceutical grade. 
Standard ETM solution.  Pharmaceutical grade 
ETM certified to be 98.97% pure was kindly supplied 
by Biocon India Ltd., Bangalore, India, and used as 
the reference standard. 
Standard ETM solutions (1 mg ml
-1, 10 and 30 
µg ml
-1) were prepared by dissolving a calculated 
quantity of pure drug in water. 
Pharmaceutical formulations of etamsylate such 
as Dicynene-250 (Dr. Reddy’s Lab.Ltd., H. P., India) 
and K-Stat-250 (Mercury, Lab. Ltd., H. P., India) were 
purchased from local markets. 
Potassium permanganate (0.02 M, 1000 and 
600 µg ml
-1). An approximately 0.02 M solution was 
prepared by dissolving 790 mg of KMnO4 (Merck, 
Mumbai, India) in water and diluting to 250 ml in a 
calibrated flask, and standardized using H. A. Bright’s 
procedure [35] and used in titrimetry. The stock stan-
dard solution was then diluted appropriately with water 
to get 1000 and 600 µg ml
-1 working concentrations 
for method A and B, respectively. 
Sulphuric acid (5 M). Concentrated acid (S. D. 
Fine Chem, Mumbai, India, sp. gr. 1.84) was appro-
priately diluted with water to get the required concen-
trations. 
Sodium hydroxide (5 M). Prepared by dissolving 
20 g of the chemical (Merck, Mumbai, India) in 100 ml 
of water. 
Table 1. Comparison of the performance characteristics of the existing spectrophotometric methods with the proposed methods 
Sl. No.  Reagent(s) used  Methodology  Linear range  Remarks  Ref. 
1.  Sodium azide and 
iodine 
The decrease in the absorbance of 
iodine is measured at 348 nm 
0.3–3.0 µg ml
-1  Sensitive but narrow linear 
range and absorbance 
measured at shorter 
wavelength 
5 
2.  Iron (III)–o-phenan-
throline mixture 
Tris-[o-phenanthroline-iron (II)] 
complex measured at 510 nm 
0.25–30 µg ml
-1 
(ε = 4.8×10
3 l mol
-1cm
-1) 
Requires heating  21 
3.  Ammonium molybdate 
(Mo
6+) 
Resulting molybdenum blue (Mo
5+) 
posses a characteristic λmax at 
695–716 nm 
2.0–70 pg ml
-1 
(ε = 2.7×10
3 l mol
-1cm
-1) 
Requires heating in a boiling 
water bath 
22 
4. Ce(IV)–MBTH
a
  The absorbance of the reaction 
product is measured at 514 nm. 
4–30 µg ml
-1  Less sensitive, uses costly 
reagent 
23 
5. KMnO4  a) Bluish green color product formed 
in alkaline medium is measured at 
610 nm 
0.5–5.0 µg ml
-1 
(ε = 2.79×10
4 l mol
-1cm
-1)
 
Highly sensitive, wide linear 
dynamic ranges, inexpensive 
instrumental setup, use of 
ecofriendly chemicals and no 
heating required 
Present 
methods
b) Unbleached color of 
permanganate in H2SO4 medium is 
measured at 545 nm 
1.5–15 µg ml
-1 
(ε = 4.17×10
4 l mol
-1cm
-1)
 
a3-Methyl-2-benzothiazolinone hydrazone hydrochloride K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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General procedure 
Titrimetry 
Different volumes (1–10 ml) of standard solution 
containing 1 mg ml
-1 ETM were taken in a 100 ml titra-
tion flask and the volume was made up to 10 ml with 
water. The solution was acidified by adding 1 ml of 5 
M H2SO4 and titrated against 0.02 M KMnO4. The 
titration was carried by a drop wise addition of KMnO4 
with continuous shaking and the end point is the first 
appearance of pink color which remains for 5 min. 
The amount of ETM in the aliquot was computed 
from the following formula: 
Amount (mg) = VMrS/n 
where V is volume of KMnO 4 solution consumed, Mr 
is relative molecular mass of drug, S is strength of 
KMnO4 (mol/L) and n is amount of KMnO4 (mol) re-
acting with 1 mol of ETM. 
Spectrophotometry 
Method A. Different aliquots of 0.5, 1.0, 2.0, 3.0, 
4.0 and 5.0 ml of standard ETM solution (10 µg ml
-1) 
were transferred into a series of 10 ml standard volu-
metric flasks and the total volume in each flask was 
adjusted to 5 ml with water. To each flask, 1 ml of 5 M 
NaOH followed by 1 ml of 1000 µg ml
-1 KMnO4 were 
added. The contents of each flask were mixed well 
and kept aside for 15 min with occasional shaking. 
The volume was made up to the mark with distilled 
water and the absorbance was measured at 610 nm 
vs reagent blank prepared in a similar manner. 
Method B. Different aliquots (0.0, 0.5, 1.0, 2.0, 
3.0, 4.0 and 5.0) ml of standard 30 µg ml
-1 ETM so-
lution were accurately measured and transferred into 
a series of 10 ml calibrated flasks by means of a mic-
roburette and the total volume was adjusted to 5 ml 
with water. To each flask 2 ml of 5 M H2SO4 and 1 ml 
of 600 µg ml
-1 KMnO4 were added using microburette. 
The contents of each flask were mixed well and kept 
aside for 15 min. The volume was made up to the 
mark with distilled water and the absorbance was 
measured at 545 nm vs  water. 
Calibration graphs were prepared by plotting 
either the increasing absorbance values in method A 
or decreasing absorbance values in method B versus 
concentrations of ETM. The concentration of the un-
known was read from the respective calibration graph 
or deduced from the regression equation derived using 
the Beer’s law data. 
Twenty tablets, each containing 250 mg of ETM, 
were weighed accurately and finely powdered. The 
quantity of the powdered tablet containing 100 mg of 
ETM was weighed accurately and transferred into a 
100 ml calibrated flask, 60 ml of water was added and 
the content shaken thoroughly for 15–20 min to extract 
the drug into the liquid phase; the volume was finally 
diluted to the mark with water, mixed well and filtered 
using a whatman No. 42 filter paper. First 10 ml of the 
filtrate was discarded, and a subsequent amount of 
the tablet extract was subjected to analysis by titri-
metry. The tablet extract containing ETM at a concen-
tration of 1 mg ml
-1 was then diluted stepwise with wa-
ter to obtain working concentrations of 10 and 30 μg 
ml
-1 in ETM for method A and B, respectively. A con-
venient aliquot was then subjected to analysis by spe-
ctrophotometric procedures described above. 
Placebo blank analysis 
A placebo blank of the composition: talc (20 
mg), starch (10 mg), acacia (15 mg), methyl cellulose 
(10 mg), sodium citrate (10 mg), magnesium stearate 
(15 mg) and sodium alginate (10 mg) was made and 
its solution was prepared as described under “tab-
lets”, and then subjected to analysis. 
Procedure for the determination of etamsylate 
in a synthetic mixture 
To the placebo blank of the composition descri-
bed above, 100 mg of ETM was added and homoge-
nized, transferred to a 100 ml standard flask and the 
solution prepared as described under tablets. The so-
lution was mixed well and filtered using a whatman 
No. 42 filter paper. The resulting solution was assay-
ed (n = 5) by titrimetry according to the same proce-
dure described above. The synthetic mixture solution 
(1 mg ml
-1 in ETM) was then diluted stepwise with 
water to obtain working concentrations of 10 and 30 
μg ml
-1 in ETM for method A and B, respectively. A 
convenient aliquot was then subjected to analysis by 
either method described above. The analysis was used 
to study the interferences of excipients such as talc, 
starch, acacia, methyl cellulose, sodium citrate, mag-
nesium stearate and sodium alginate. 
RESULTS AND DISCUSSION 
Method development 
Numerous inorganic and organic substances 
have been determined using KMnO4 as the oxidimet-
ric reagent [36,37]. A close examination of the lite-
rature survey presented in the introduction part reveals 
that KMnO4 has not been used for the spectrophoto-
metric determination of ETM. Hence, the reaction be-
tween ETM and KMnO4 was investigated based on 
which one titrimetric and two spectrophotometric me-
thods were developed. In titrimetry, ETM is directly 
titrated against KMnO4 in sulphuric acid medium. The K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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end point was detected by the first appearance of pink 
color which remained for 5 min. The reaction stoichio-
metry was found to be 1:4 (ETM:KMnO4). Both spec-
trophotometric methods are based on the oxidation of 
ETM by KMnO4 either in basic medium (method A) or 
in acid medium (method B). In method A, an excess 
of KMnO4 was added to ETM in NaOH medium fol-
lowed by the determination of manganate (K2MnO4) 
which is bluish-green in color, resulting from the re-
duction of KMnO4 by ETM. The increase in the absor-
bance was measured at 610 nm (Fig. 2a). In method 
B, the residual oxidant after the complete oxidation of 
ETM by a measured excess of KMnO4 in H2SO4 me-
dium was determined by measuring its decrease in ab-
sorbance at 545 nm (Fig. 2b). In titrimetric method and 
spectrophotometric method B, the amount of KMnO4 
reacted corresponds to the amount of drug which ser-
ved as the basis of the assay. 
The various experimental parameters were opti-
mized and used throughout the experiment. 
 
(a) 
 
(b) 
Figure 2. Calibration curve for method A (a) and B (b). 
Optimization of variables 
Efforts were made to increase the sensitivity of 
the methods by finding the optimum concentration of 
each reactant. 
In titrimetry, the reaction was found to be stoi-
chiometric in H2SO4 medium. Reproducible and stoi-
chiometric results were obtained when 0.45–2.27 M 
H2SO4 was maintained. Hence, 1 ml of 5 M H2SO4 so-
lution in a total volume of 11 ml was found to be the 
most suitable concentration for a quantitative reaction 
between ETM and KMnO4. The reaction stoichiometry 
was calculated to be 1:4 (ETM:KMnO4) in the 1–10 mg 
range. Below and above these limits, irregular stoi-
chiometries were obtained. As the reaction between 
ETM and KMnO4 was a little bit slow, the titration was 
carried out by the dropwise addition of KMnO4 solu-
tion and a continuous shaking during the titration, to 
the first appearance of pink color which remained for 
5 min. 
Spectrophotometry 
Method A 
Potassium permanganate quantitatively oxidizes 
ETM in the NaOH medium and reduces itself to man-
ganate ion – the bluish green colored chromogen 
[38,39] which absorbs maximally at 610 nm (Fig. 3). 
The experimental variables for the formation of the 
stable and sensitive colored product were optimized. 
Even though a higher concentration of the KMnO4 re-
sulted in increased sensitivity of the method, blank 
absorbance also increased concomitantly. Hence, 1 
ml of 1000 µg ml
-1 KMnO4 in a total volume of 10 ml 
was fixed which showed the maximum absorbance 
associated with a minimum blank reading (Fig. 4a). 
The absorbance readings were maximum and almost 
constant with an overall NaOH concentration of 0.5– 
–1.2 M was maintained at a drug concentration of 4 µg 
ml
-1 (Fig. 4b). 1 ml of 5 M NaOH in a total volume of 
10 ml was determined to be optimum for the reaction. 
The reaction was complete in 15 min and any delay up 
to 35 min had no effect on the absorbance (Fig. 4c). 
 
 
Figure 3. Absorption spectra of method A (Bluish green color 
produced for 4 µg ml
-1). K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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(a) 
 
(b) 
 
(c) 
Figure 4. Effect of a) KMnO4, b) NaOH and c) reaction time 
(Method A); 4 µg ml
-1 ETM. 
Method B 
Preliminary experiments were performed to de-
termine the maximum concentration of KMnO4 which 
gave the maximum absorbance at 545 nm in the acid 
medium employed and this was found to be 60 µg ml
-1 
(Fig. 5). Since the oxidation reactions with permanga-
nate are usually performed in H2SO4 medium [40], the 
reaction of the oxidant with the drug was carried out in 
H2SO4 medium. When a fixed concentration of per-
manganate was reacted with increasing concentra-
tions of ETM in H2SO4 medium, a concomitant fall in 
the concentration of permanganate occurred, as shown 
by the decreasing absorbance at 545 nm (Fig. 6). 
Hence, different concentrations of ETM were reacted 
with 1 ml of 600 µg ml
-1 KMnO4 to determine the con-
centration range over which ETM could be determi-
ned. To check the effect of H2SO4 concentration on 
the reaction, 1–4 ml of 5 M H2SO4 was added to a fix-
ed concentration of ETM (9 µg ml
-1) and KMnO4 (60 
µg ml
-1), and it was observed that constant absor-
bance readings were obtained when 2-4 ml of 5 M 
H2SO4 in a total volume of 10 ml was used (Fig. 7a). 
Hence, 2 ml of 5 M H2SO4 was fixed. The reaction 
was found to be complete and quantitative when the 
reaction mixture was allowed to stand for 15 min, and 
beyond this standing time up to 30 min the absor-
bance remain constant (Fig. 7b). 
 
Figure 5. Effect of KMnO4 (Method B). 
 
Figure 6. Effect of ETM concentration on the absorbance of 
60 µg ml
-1 KMnO4 (Method B). 
Method validation procedures 
The proposed method has been validated for li-
nearity, sensitivity, precision, accuracy, selectivity and 
recovery. 
Linearity and sensitivity 
Over the range investigated (1–10 mg), a fixed 
stoichiometry of 1:4 (ETM:KMnO4) was obtained in tit-
rimetry which served as the basis for calculations. In 
spectrophotometry, under optimum conditions a linear 
relation was obtained between absorbance and con-
centration of ETM in the range 0.5–5.0 µg ml
-1 in me-
thod A and 1.5–15µg ml
-1 in method B. The calibration 
graph is described by the equation: 
y = a + bx K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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where y is absorbance, a is intercept, b is slope and x 
is concentration) obtained by the method of least 
squares. The correlation coefficient, intercept and slo-
pe for the calibration data are summarized in Table 2. 
Sensitivity parameters such as apparent molar absor-
ptivity and sandell sensitivity values, the limits of de-
tection and quantification are calculated as per the 
current ICH guidelines [41] are compiled in Table 2 
speak of the excellent sensitivity of the proposed me-
thods. The limits of detection (LOD) and quantification 
(LOQ) were calculated according to the same guide-
lines using the formula: 
LOD = 3.3σ/s 
and 
LOQ = 10σ/s 
where  σ is the standard deviation of five reagent 
blank determinations and s is the slope of the calibra-
tion curve. 
Table 2. Sensitivity and regression parameters 
Parameter  Method A  Method B 
λmax, nm  610  545 
Linear range, µg ml
-1 0.5–5.0 
  1.5–15
 
Molar absorptivity (ε), l mol
-1 cm
-1 2.79×10
4  4.2×10
4 
Sandell sensitivity
a, µg cm
-2 0.0094  0.0063 
Limit of detection (LOD), μg ml
-1 0.06  0.14 
Limit of quantification (LOQ), μg ml
-1 0.18  0.42 
Regression equation, y
b 
Intercept (a) 0.0000  +0.860 
Slope (b) 0.095  –0.046 
Standard deviation of a (Sa) 0.012  0.145 
Standard deviation of b (Sb) 0.003  0.011 
Regression coefficient (r) 0.998  –0.999 
aLimit of determination as the weight in µg per ml of solution, which cor-
responds to an absorbance of A = 0.001 measured in a cuvette of cross-
sectional area 1 cm
2 and l = 1 cm; 
by = a + bx, where y is the absorbance, 
x is concentration, a is intercept, b is slope. 
Precision and accuracy 
Intra-day precision and accuracy of the propo-
sed methods were evaluated by the replicate analysis 
(n = 5) of calibration standards at three different con-
centration levels on the same day. Inter-day precision 
and accuracy were determined by assaying the cali-
bration standards at the same concentration levels on 
five consecutive days. The precision and accuracy 
were based on five consecutive days. The precision 
and accuracy were based on the calculated relative 
standard deviation (RSD, %) and relative error (RE, 
%) of the found concentration compared to the theo-
retical one, respectively (Table 3). 
Selectivity 
The proposed methods were tested for selecti-
vity by placebo blank and synthetic mixture analysis. 
A convenient aliquot of the placebo blank solution 
prepared as described earlier was subjected to ana-
lysis by titrimetry and spectrophotometry (methods A 
and B) according to the recommended procedures. In 
all the cases, there was no interference by the inac-
tive ingredients. 
A separate experiment was performed with the 
synthetic mixture. The analysis of the synthetic mix-
ture solution prepared above yielded percent recove-
ries ranged between 93.8 and 112.8 with standard 
deviation of 0.82–1.94 in all the cases. The results of 
this study are presented in Table 4 indicating that the 
inactive ingredients did not interfere in the assay. 
These results further demonstrate the accuracy as 
well as the precision of the proposed methods. 
Application to formulations 
In order to evaluate the analytical applicability of 
the proposed method to the quantification of ETM in 
commercial tablets, the results obtained by the pro-
posed methods were compared to those of the refe-
rence method [42] by applying student’s t-test for ac-
curacy and F-test for precision. The results (Table 5) 
show that the Student’s t- and F-values at 95% con-
          
 (a)  (b) 
Figure 7. Effect of a) H2SO4 and b) the reaction time (Method B; 9 µg ml
-1ETM). K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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fidence level are less than the theoretical values, 
which confirmed that there is a good agreement be-
tween the results obtained by the proposed methods 
and the reference method with respect to accuracy 
and precision. 
Table 4. Recovery of the drug from the synthetic mixture 
Method 
ETM in synthetic 
mixture taken
a 
ETM recoverd
b (±SD)
% 
Titrimetry 3.0  99.74±0.98 
6.0 101.2±0.82 
9.0 102.7±1.16 
Spectrophotometric 
method A 
1.0 97.06±1.05 
2.0 95.75±0.94 
3.0 93.82±1.11 
Spectrophotometric 
method B 
3.0 108.1±1.67 
6.0 112.8±1.94 
9.0 96.83±1.08 
amg in titrimetry and µg ml
-1 in spectrophotometry; 
bmean value of five 
determinations 
Recovery studies 
The accuracy and validity of the proposed me-
thods were further ascertained by performing reco-
very studies. Pre-analyzed tablet powder was spiked 
with pure ETM at three concentration levels (50, 100 
and 150% of that in tablet powder) and the total was 
found by the proposed methods. In all cases, the ad-
ded ETM recovery percentage values ranged be-
tween 98.7 and 126% with standard deviation of 0.54– 
-1.78 (Table 6) indicating that the recovery was good, 
and that the co-formulated substance did not interfere 
in the determination. 
CONCLUSIONS 
The proposed titrimetric method is the first re-
port on the application of titrimetry for the assay of 
etamsylate. The titrimetric method is straightforward 
and fast when compared to the other methods repor-
ted earlier. The spectrophotometric methods employ 
Table 3. Evaluation of intra-day and inter-day accuracy and precision 
Method
  ETM taken
a 
Intra-day accuracy and precision  Inter-day accuracy and precision 
ETM found  RE
b, %  RSD
c, %  ETM found  RE, %  RSD, % 
Titrimetry  2.0  1.99  0.5  1.05 1.97 1.50 2.76 
4.0  3.98  0.5  1.46 3.90 2.50 2.58 
6.0  6.11  1.8  1.17 5.89 1.83 2.28 
Spectrophotometric  method  A  1.0  0.98 2.00 1.58 0.97 3.00 3.66 
2.0  1.96 2.00 1.76 1.95 2.50 4.05 
3.0  2.95 1.67 2.14 2.90 3.33 3.78 
Spectrophotometric  method  B  3.0  3.07 2.33 1.17 2.91 3.00 3.32 
6.0  6.05 0.83 0.22 5.84 2.67 2.96 
9.0  8.95 0.55 1.23 8.67 3.67 2.76 
aIn titrimetry, ETM taken/found are in mg and they are µg ml
-1 in spectrophotometry;  
brelative error; 
c relative standard deviation 
Table 5. Results of analysis of tablets by the proposed methods 
Tablet brand name
  Label claim 
mg/tablet 
Found
a (±SD), % (label claim) 
Reference method  Titrimetry 
Spectrophotometry 
Method A  Method B 
K-Stat
b 250  250  98.66±1.14  99.32±0.66 
t
f = 1.12 
F
g = 2.98 
100.1±1.41 
t = 1.78 
F = 1.53 
98.74±1.52 
t = 0.09 
F = 1.78 
Dicynene
c 250  250  101.3±0.85  102.1±1.14 
t = 1.26 
F = 1.79 
100.4±1.26 
t = 1.33 
F = 2.19 
99.67±1.74 
t = 1.89 
F = 4.19 
Hemsyl
d 250  250  97.16±0.92  96.57±1.42 
t = 0.78 
F = 2.38 
97.67±1.06 
t = 0.81 
F = 1.33 
96.76±1.24 
t = 0.58 
F = 1.82 
Sylate
e 250  250  93.45±1.32  92.86±1.04 
t = 0.78 
F = 1.61 
93.06±1.11 
t = 0.51 
F = 1.41 
92.84±1.36 
t = 0.72 
F = 1.06 
aMean value of five determinations; 
bMercury, Lab. Ltd., H. P., India; 
cDr. Reddy’s Lab. Ltd., H. P., India; 
dIndoco Rem. Ltd., Mumbai, India; 
eEmcure Pharm. 
Ltd., Pune, India; 
fthe value at 95% confidence level and for four degrees of freedom is 2.77; 
gthe value at 95% confidence level and for four degrees of 
freedom is 6.39 K. B. VINAY et al.: PERMANGANOMETRIC DETERMINATION OF ETAMSYLATE…  CI&CEQ 15 (3) 149−157 (2009) 
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mild working conditions without heating or extraction. 
The methods are based on well established and cha-
racterized redox reactions and use cheaper and rea-
dily available chemicals. These methods are good al-
ternative to a few reported methods with respect to 
speed, simplicity, sensitivity, selectivity, cost-effecti-
veness and the stability of the measured species. 
Though the sodium azide method [5] looks sensitive, 
the absorbance is measured at 348 nm where the in-
terference from the co-formulated substances is far 
more than at longer wavelengths used in the present 
methods. The methods have been demonstrated to 
be free from common tablet excipients and additives. 
These merits coupled with the use of a simple and in-
expensive instrument, recommend the use of the me-
thods in routine quality control Laboratories. 
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